The role of pharmacology in ureteral physiology and expulsive therapy

Travis Jerde, Stephen Y. Nakada

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Research in the field of ureteral physiology and pharmacology has traditionally been directed toward relaxation of ureteral spasm as a mechanism of analgesia during painful ureteral obstruction, most often stone-induced episodes. However, interest in this field has expanded greatly in recent years with the expanded use of alpha-blocker therapy for inducing stone passage, a usage now termed "medical expulsive therapy". While most clinical reports involving expulsive therapy have focused on alpha receptor or calcium channel blockade, there are diverse studies investigating pharmacological ureteral relaxation with novel agents including cyclooxygenase inhibitors, small molecule beta receptor agonists, neurokinin antagonists, and phosphodiesterase inhibitors. In addition, cutting edge molecular biology research is revealing promising potential therapeutic targets aimed at specific molecular changes that occur during the acute obstruction that accompanies stone disease. The purpose of this report is to review the use of pharmacological agents as ureteral smooth muscle relaxants clinically, and to look into the future of expulsive therapy by reviewing the available literature of ureteral physiology and pharmacology research.

Original languageEnglish (US)
Title of host publicationAIP Conference Proceedings
Pages262-271
Number of pages10
Volume900
StatePublished - 2007
Externally publishedYes
Event1st Annual International Urolithiasis Research Symposium - Indianapolis, IN, United States
Duration: Nov 2 2006Nov 3 2006

Other

Other1st Annual International Urolithiasis Research Symposium
CountryUnited States
CityIndianapolis, IN
Period11/2/0611/3/06

Fingerprint

pharmacology
physiology
therapy
rocks
inhibitors
muscle relaxants
analgesia
spasms
molecular biology
smooth muscle
reviewing
calcium
molecules

Keywords

  • Expulsive therapy
  • Pharmacology
  • Relaxation
  • Smooth muscle
  • Ureter

ASJC Scopus subject areas

  • Physics and Astronomy(all)

Cite this

Jerde, T., & Nakada, S. Y. (2007). The role of pharmacology in ureteral physiology and expulsive therapy. In AIP Conference Proceedings (Vol. 900, pp. 262-271)

The role of pharmacology in ureteral physiology and expulsive therapy. / Jerde, Travis; Nakada, Stephen Y.

AIP Conference Proceedings. Vol. 900 2007. p. 262-271.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Jerde, T & Nakada, SY 2007, The role of pharmacology in ureteral physiology and expulsive therapy. in AIP Conference Proceedings. vol. 900, pp. 262-271, 1st Annual International Urolithiasis Research Symposium, Indianapolis, IN, United States, 11/2/06.
Jerde T, Nakada SY. The role of pharmacology in ureteral physiology and expulsive therapy. In AIP Conference Proceedings. Vol. 900. 2007. p. 262-271
Jerde, Travis ; Nakada, Stephen Y. / The role of pharmacology in ureteral physiology and expulsive therapy. AIP Conference Proceedings. Vol. 900 2007. pp. 262-271
@inproceedings{218d7456d58c405c9a92f42775fafd69,
title = "The role of pharmacology in ureteral physiology and expulsive therapy",
abstract = "Research in the field of ureteral physiology and pharmacology has traditionally been directed toward relaxation of ureteral spasm as a mechanism of analgesia during painful ureteral obstruction, most often stone-induced episodes. However, interest in this field has expanded greatly in recent years with the expanded use of alpha-blocker therapy for inducing stone passage, a usage now termed {"}medical expulsive therapy{"}. While most clinical reports involving expulsive therapy have focused on alpha receptor or calcium channel blockade, there are diverse studies investigating pharmacological ureteral relaxation with novel agents including cyclooxygenase inhibitors, small molecule beta receptor agonists, neurokinin antagonists, and phosphodiesterase inhibitors. In addition, cutting edge molecular biology research is revealing promising potential therapeutic targets aimed at specific molecular changes that occur during the acute obstruction that accompanies stone disease. The purpose of this report is to review the use of pharmacological agents as ureteral smooth muscle relaxants clinically, and to look into the future of expulsive therapy by reviewing the available literature of ureteral physiology and pharmacology research.",
keywords = "Expulsive therapy, Pharmacology, Relaxation, Smooth muscle, Ureter",
author = "Travis Jerde and Nakada, {Stephen Y.}",
year = "2007",
language = "English (US)",
isbn = "0735404062",
volume = "900",
pages = "262--271",
booktitle = "AIP Conference Proceedings",

}

TY - GEN

T1 - The role of pharmacology in ureteral physiology and expulsive therapy

AU - Jerde, Travis

AU - Nakada, Stephen Y.

PY - 2007

Y1 - 2007

N2 - Research in the field of ureteral physiology and pharmacology has traditionally been directed toward relaxation of ureteral spasm as a mechanism of analgesia during painful ureteral obstruction, most often stone-induced episodes. However, interest in this field has expanded greatly in recent years with the expanded use of alpha-blocker therapy for inducing stone passage, a usage now termed "medical expulsive therapy". While most clinical reports involving expulsive therapy have focused on alpha receptor or calcium channel blockade, there are diverse studies investigating pharmacological ureteral relaxation with novel agents including cyclooxygenase inhibitors, small molecule beta receptor agonists, neurokinin antagonists, and phosphodiesterase inhibitors. In addition, cutting edge molecular biology research is revealing promising potential therapeutic targets aimed at specific molecular changes that occur during the acute obstruction that accompanies stone disease. The purpose of this report is to review the use of pharmacological agents as ureteral smooth muscle relaxants clinically, and to look into the future of expulsive therapy by reviewing the available literature of ureteral physiology and pharmacology research.

AB - Research in the field of ureteral physiology and pharmacology has traditionally been directed toward relaxation of ureteral spasm as a mechanism of analgesia during painful ureteral obstruction, most often stone-induced episodes. However, interest in this field has expanded greatly in recent years with the expanded use of alpha-blocker therapy for inducing stone passage, a usage now termed "medical expulsive therapy". While most clinical reports involving expulsive therapy have focused on alpha receptor or calcium channel blockade, there are diverse studies investigating pharmacological ureteral relaxation with novel agents including cyclooxygenase inhibitors, small molecule beta receptor agonists, neurokinin antagonists, and phosphodiesterase inhibitors. In addition, cutting edge molecular biology research is revealing promising potential therapeutic targets aimed at specific molecular changes that occur during the acute obstruction that accompanies stone disease. The purpose of this report is to review the use of pharmacological agents as ureteral smooth muscle relaxants clinically, and to look into the future of expulsive therapy by reviewing the available literature of ureteral physiology and pharmacology research.

KW - Expulsive therapy

KW - Pharmacology

KW - Relaxation

KW - Smooth muscle

KW - Ureter

UR - http://www.scopus.com/inward/record.url?scp=34248233088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248233088&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:34248233088

SN - 0735404062

SN - 9780735404069

VL - 900

SP - 262

EP - 271

BT - AIP Conference Proceedings

ER -